Vascepa is a prescription drug used to lower high triglyceride levels in adults. According to [1], Vascepa is a brand-name drug with no generic alternative, and its patent will expire in 2030. The drug's manufacturer, Amarin Corporation, offers a savings program to eligible patients to help them afford the medication. Patients can save up to $70 on each prescription refill, and the program covers up to 12 uses. The savings program is available to patients with or without insurance, but it cannot be used in conjunction with any government-funded insurance, including Medicare and Medicaid.

SingleCare, a healthcare savings program, also offers discounts on Vascepa. According to [3], SingleCare users can save up to 80% on the cost of Vascepa. However, the actual discount may vary depending on the pharmacy and the specific Vascepa product. Patients can search for Vascepa prices on the SingleCare website or app and compare prices at different pharmacies.

In conclusion, Vascepa discounts can save patients up to $70 per refill through the manufacturer's savings program. Additionally, SingleCare users can save up to 80% on the cost of Vascepa, but the discount may vary depending on the pharmacy and the specific product. It's important to note that these savings programs cannot be used in conjunction with government-funded insurance. Patients should consult with their healthcare provider to determine if Vascepa is the right medication for them and to discuss any available cost-saving options.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.vascepa.com/getting-started/vascepa-savings/
[3] https://www.singlecare.com/blog/vascepa-without-insurance/